Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- Raj Ratwani Appointed to Newly Created Vice President of Scientific Affairs Position
As part of our continued progress toward becoming a world-class academic health system, and advancin... - MedStar Investigators Examine Patient Safety Issues from the EHR Surveillance Program
Researchers from MedStar Health National Center for Human Factors in Healthcare and Georgetown Unive... - December Peer-Reviewed Publications from MedStar Health
Congratulations to all MedStar researchers who had articles published in December 2019. The selected...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]